Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Iman Mansour, Rania A. Zayed, Fadwa Said & Lamyaa Abdel Latif. (2016) Indoleamine 2,3-dioxygenase and regulatory T cells in acute myeloid leukemia. Hematology 21:8, pages 447-453.
Read now
Read now
H Eichler, Xd Nguyen, D Roelen, Cm Celluzzi, D McKenna, D Pamphilon, A Blair, Ej Read, Ta Takahashi & Zm Szczepiorkowski. (2008) Multicenter study on in vitro characterization of dendritic cells. Cytotherapy 10:1, pages 21-29.
Read now
Read now
Owen Proudfoot, Dodie Pouniotis, Kuo-Ching Sheng, Bruce E Loveland & Geoffrey A Pietersz. (2007) Dendritic cell vaccination. Expert Review of Vaccines 6:4, pages 617-633.
Read now
Read now
Ka Ward, La Stewart & Ap Schwarer. (2006) CD34+-derived CD11c+ + + BDCA-1+ + CD123+ + DC: expansion of a phenotypically undescribed myeloid DC1 population for use in adoptive immunotherapy. Cytotherapy 8:2, pages 130-140.
Read now
Read now
Articles from other publishers (19)
Poorva Bindal, Jacalyn Rosenblatt & David Avigan. (2021) Therapeutic dendritic cell cancer vaccines in hematologic malignancies. ImmunoMedicine 1:1.
Crossref
Crossref
Mable Wing Yan Chan & Sowmya Viswanathan. (2019) Recent progress on developing exogenous monocyte/macrophage-based therapies for inflammatory and degenerative diseases. Cytotherapy 21:4, pages 393-415.
Crossref
Crossref
Mariangela Lecciso, Darina Ocadlikova, Sabina Sangaletti, Sara Trabanelli, Elena De Marchi, Elisa Orioli, Anna Pegoraro, Paola Portararo, Camilla Jandus, Andrea Bontadini, Annarita Redavid, Valentina Salvestrini, Pedro Romero, Mario P. Colombo, Francesco Di Virgilio, Michele Cavo, Elena Adinolfi & Antonio Curti. (2017) ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells. Frontiers in Immunology 8.
Crossref
Crossref
Matthew Weinstock, Jacalyn Rosenblatt & David Avigan. (2017) Dendritic Cell Therapies for Hematologic Malignancies. Molecular Therapy - Methods & Clinical Development 5, pages 66-75.
Crossref
Crossref
Matthias Eyrich, Susanne C. Schreiber, Johannes Rachor, Jürgen Krauss, Femke Pauwels, Johannes Hain, Matthias Wölfl, Manfred B. Lutz, Steven de Vleeschouwer, Paul G. Schlegel & Stefaan W. Van Gool. (2014) Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells. Cytotherapy 16:7, pages 946-964.
Crossref
Crossref
Sarah J. Albon, Christoph Mancao, Kimberly Gilmour, Geoffrey White, Ida Ricciardelli, Jennifer Brewin, Gertjan Lugthart, Rebecca Wallace & Persis J. Amrolia. (2013) Optimization of methodology for production of CD25/CD71 allodepleted donor T cells for clinical use. Cytotherapy 15:1, pages 109-121.
Crossref
Crossref
Jooeun Bae, R. H. Prabhala & Nikhil C. Munshi. 2013. Advances in Biology and Therapy of Multiple Myeloma. Advances in Biology and Therapy of Multiple Myeloma
131
154
.
Rédouane Rouas, Haidar Akl, Hussein Fayyad-Kazan, Nabil El Zein, Bassam Badran, Bérangère Nowak, Hugues Duvillier, Philippe Martiat & Philippe Lewalle. (2010) Dendritic Cells Generated in Clinical Grade Bags Strongly Differ in Immune Functionality When Compared With Classical DCs Generated in Plates. Journal of Immunotherapy 33:4, pages 352-363.
Crossref
Crossref
Henk S.P. Garritsen, Lars Macke, Wilhelm Meyring, Horst Hannig, Ute Pägelow, Bernhard Wörmann, Robert Geffers, Kurt E.J. Dittmar & Werner Lindenmaier. (2010) Efficient generation of clinical-grade genetically modified dendritic cells for presentation of multiple tumor-associated proteins. Transfusion 50:4, pages 831-842.
Crossref
Crossref
Yoon Jeong Heo, Cheol Hun Son, Joo-Seop Chung, You-Soo Park & Jeong Hwa Son. (2009) The cryopreservation of high concentrated PBMC for dendritic cell (DC)-based cancer immunotherapy. Cryobiology 58:2, pages 203-209.
Crossref
Crossref
M Arpinati, G Chirumbolo, B Nicolini, C Agostinelli & D Rondelli. (2008) Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade). Bone Marrow Transplantation 43:3, pages 253-259.
Crossref
Crossref
Sri Ramulu Elluru, Jean-Paul Duong van Huyen, Sandrine Delignat, Michel D Kazatchkine, Alain Friboulet, Srini V Kaveri & Jagadeesh Bayry. (2008) Induction of maturation and activation of human dendritic cells: A mechanism underlying the beneficial effect of Viscum albumas complimentary therapy in cancer. BMC Cancer 8:1.
Crossref
Crossref
I Hus, M Schmitt, J Tabarkiewicz, S Radej, K Wojas, A Bojarska-Junak, A Schmitt, K Giannopoulos, A Dmoszyńska & J Roliński. (2008) Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response. Leukemia 22:5, pages 1007-1017.
Crossref
Crossref
Pierre-Joseph Royer, Gwenola Bougras, Frederic Ebstein, Lucie Leveque, Severine Tanguy-Royer, Thomas Simon, Nadine Juge-Morineau, Patrice Chevallier, Jean-Luc Harousseau & Marc Gregoire. (2008) Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: Application to active immunotherapy. Experimental Hematology 36:3, pages 329-339.
Crossref
Crossref
William K. Decker, Sufang Li, Dongxia Xing, Simon N. Robinson, Hong Yang, David Steiner, Krishna V. Komanduri, Catherine M. Bollard & Elizabeth J. Shpall. (2008) Deficient TH-1 Responses From TNF-α–matured and α-CD40–matured Dendritic Cells. Journal of Immunotherapy 31:2, pages 157-165.
Crossref
Crossref
Antonio Curti, Patrizia Tosi, Patrizia Comoli, Carolina Terragna, Elisa Ferri, Claudia Cellini, Massimo Massaia, Alessandra D’Addio, Valeria Giudice, Cristiana Di Bello, Michele Cavo, Roberto Conte, Gabriele Gugliotta, Michele Baccarani & Roberto M. Lemoli. (2007) Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides. British Journal of Haematology 139:3, pages 415-424.
Crossref
Crossref
Michael Erdmann, Jan Dörrie, Niels Schaft, Erwin Strasser, Martin Hendelmeier, Eckhart Kämpgen, Gerold Schuler & Beatrice Schuler-Thurner. (2007) Effective Clinical-scale Production of Dendritic Cell Vaccines by Monocyte Elutriation Directly in Medium, Subsequent Culture in Bags and Final Antigen Loading Using Peptides or RNA Transfection. Journal of Immunotherapy 30:6, pages 663-674.
Crossref
Crossref
Viskam Wijewardana, Kikuya Sugiura, Tomoko Oichi, Mariko Fujimoto, Takashi Akazawa, Shingo Hatoya, Muneo Inaba, Susumu Ikehara, Thotawaththege S.P. Jayaweera & Toshio Inaba. (2006) Generation of canine dendritic cells from peripheral blood monocytes without using purified cytokines. Veterinary Immunology and Immunopathology 114:1-2, pages 37-48.
Crossref
Crossref
Mitsuru Sakakibara, Tatsuya Kanto, Michiyo Inoue, Aki Kaimori, Takayuki Yakushijin, Hideki Miyatake, Ichiyo Itose, Masanori Miyazaki, Noriyoshi Kuzushita, Naoki Hiramatsu, Tetsuo Takehara, Akinori Kasahara & Norio Hayashi. (2006) Quick Generation of Fully Mature Dendritic Cells From Monocytes With OK432, Low-Dose Prostanoid, and Interferon-?? as Potent Immune Enhancers. Journal of Immunotherapy 29:1, pages 67-77.
Crossref
Crossref